Catabasis Pharmaceuticals, Inc. stock price

Catabasis Pharmaceuticals, Inc. latest news:

  • 11/09/2017 15:16:17

    BRIEF-Catabasis Pharmaceuticals reports third quarter financial results

    Catabasis Pharmaceuticals Inc(CATB). * Catabasis Pharmaceuticals(CATB) reports third quarter 2017 financial results and reviews business progress. * Q3 loss per share $0.31. * Q3 earnings per share view $-0.33 -- Thomson Reuters I/B/E/S. * Catabasis Pharmaceuticals Inc (CATB) - co's current operating plan provides for cash to fund operations through august 2018‚Äč Source text for Eikon: Further company coverage:

  • More trends:

    Catalyst Inc. CBIO | Catalyst Pharmaceuticals, Inc.CPRX | Cathay General BancorpCATY | Cathay General BancorpCATYW | Cavco Industries, Inc.CVCO | Cavium, Inc.CAVM | CB Financial Services, Inc.CBFV | CB Pharma Acquisition Corp.CNLM | CB Pharma Acquisition Corp.CNLMR | CB Pharma Acquisition Corp.CNLMU |